Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma

1. Tiong LMaddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-24.10.1002/bjs.7669Search in Google Scholar

2. Fuchs T, Kachelriess MKalender WA. Technical advances in multi-slice spiral CT. Eur J Radiol 2000; 36: 69-73.10.1016/S0720-048X(00)00269-2Search in Google Scholar

3. Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Hepatol Res 2007; 37(Suppl 2): S193-9.10.1111/j.1872-034X.2007.00184.x17877482Search in Google Scholar

4. Okamoto E, Sato S, Sanchez-Siles AA, Ishine J, Miyake T, Amano Y, et al. Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: a prospective pilot study. AJR Am J Roentgenol 2010; 194: 1272-8.10.2214/AJR.08.229420410414Search in Google Scholar

5. Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hatanaka K, et al. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007; 72(Suppl 1): 111-6.10.1159/00011171618087191Search in Google Scholar

6. Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, et al. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res 2008; 38: 565-71.10.1111/j.1872-034X.2007.00308.x18218008Search in Google Scholar

7. Kawasoe H, Eguchi Y, Mizuta T, Yasutake T, Ozaki I, Shimonishi T, et al. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. JClin Biochem Nutr 2007; 40: 66-72.10.3164/jcbn.40.66229150618437215Search in Google Scholar

8. Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, et al. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 2009; 32: 62-9.10.1007/s00270-008-9462-x18987911Search in Google Scholar

9. Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, et al. Contrast enhanced ultrasound of hepatocellular carcinoma. World J Radiol 2010; 2: 68-82.10.4329/wjr.v2.i2.68299892521160920Search in Google Scholar

10. Minami Y, Kudo M, Hatanaka K, Kitai S, Inoue T, Hagiwara S, et al. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int 2010; 30: 759-64.10.1111/j.1478-3231.2010.02226.x20456042Search in Google Scholar

11. Masuzaki R, Shiina S, Tateishi R, Yoshida H, Goto E, Sugioka Y, et al. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26: 759-64.10.1111/j.1440-1746.2010.06559.x21054516Search in Google Scholar

12. Numata K, Morimoto M, Ogura T, Sugimori K, Takebayashi S, Okada M, et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. JUltrasound Med 2008; 27: 395-406.10.7863/jum.2008.27.3.39518314518Search in Google Scholar

13. Bruix JSherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.10.1002/hep.2093316250051Search in Google Scholar

14. Kokudo NMakuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 2009; 44(Suppl 19): 119-21.10.1007/s00535-008-2244-z19148805Search in Google Scholar

15. Kim YS, Lee WJ, Rhim H, Lim HK, Choi DLee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 2010; 195: 758-65.10.2214/AJR.09.295420729457Search in Google Scholar

16. Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56: 66-73.10.1016/j.ejrad.2005.03.02315913940Search in Google Scholar

17. Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, et al. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol 2007; 33: 1736-49.10.1016/j.ultrasmedbio.2007.05.00417629608Search in Google Scholar

18. Kisaka Y, Hirooka M, Kumagi T, Uehara T, Hiasa Y, Kumano S, et al. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006; 26: 1241-7.10.1111/j.1478-3231.2006.01367.x17105590Search in Google Scholar

19. Kisaka Y, Hirooka M, Koizumi Y, Abe M, Matsuura B, Hiasa Y, et al. Contrastenhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. J Clin Ultrasound 2010; 38: 138-44.Search in Google Scholar

20. Landmark KE, Johansen PW, Johnson JA, Johansen B, Uran SSkotland T. Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity. Ultrasound Med Biol 2008; 34: 494-501.10.1016/j.ultrasmedbio.2007.09.01918096304Search in Google Scholar

21. Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, et al. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system. Oncol Rep 2010; 23: 493-7.Search in Google Scholar